Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:1e)/PE(38:0p) | KDO | 0.0 | BCG061213A03 | 81.4 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 0.0 | BCG061213C03 | 66.2 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 0.0 | BCG061213B03 | 84.7 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 6.0 | BCG061213B02 | 39.8 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 6.0 | BCG061213C02 | 32.4 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 6.0 | BCG061213A02 | 32.9 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 24.0 | BCG061213C01 | 80.4 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 24.0 | BCG061213A01 | 81.7 | pmol/1E6 cells |
| - | PE(38:1e)/PE(38:0p) | KDO | 24.0 | BCG061213B01 | 99.2 | pmol/1E6 cells |